Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized ...

Bain Capital Specialty Finance Inc (NYSE:BCSF) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate ...

Bain Capital Specialty Finance Inc (NYSE:BCSF) is set to release its Q2 2025 earnings on Aug 5, 2025. The consensus estimate ...

Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...

Good morning, and welcome, everyone, to the Bain Capital Specialty Finance Second Quarter ended June 30, 2025 Conference Call. Yesterday, after market close, we issued our earnings press release and ...

Bain Capital Specialty Finance shares strong Q2 2025 results with 10.7% annualized yield, rising originations, stable dividends, and robust credit quality.

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized initial public offering in the United States, indicating robust investor ...

Bain Capital and 11North Partners paid $395 million for a portfolio of 10 shopping centers in Florida and South Carolina, ...

Endeavour has been under considerable pressure to turn around its share price decline, and earlier this week told investors ...

Bristol Myers Squibb (BMS) and Bain Capital have created an independent biopharmaceutical company to develop immunology ...

A joint venture between Bain Capital and 11North Partners has purchased a portfolio of 10 open-air retail centers in Florida ...

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...